Document:

Exhibit
4.14

 

DESCRIPTION
OF SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934

 

As
of May 14, 2020, NanoVibronix, Inc., a Delaware corporation (“we,” “our” and the “Company”) has its
common stock, par value $0.001 per share, registered under Section 12 of the Securities Exchange Act of 1934, as amended.

 

The
following description is intended as a summary and is qualified in its entirety by reference to our amended and restated certificate
of incorporation, as amended (the “Amended & Restated Certificate of Incorporation”) and the amended and restated by-laws,
as amended (the “By-laws”) as currently in effect, copies of which are filed as exhibits to this Annual Report on Form 10-K
and are incorporated by reference herein.

 

Authorized
Capital Stock

 

As
of April 14, 2022, our authorized capital stock consists of 51,000,000 shares, of which 40,000,000 shares are common stock, par
value $0.001 per share, and 11,000,000 shares are preferred stock, par value $0.001 per share, 3,000,000 of which have been designated
as Series C Convertible Preferred Stock (“Series C Preferred Stock”), 506 of which have been designated as Series D Convertible
Preferred Stock (“Series D Preferred Stock”) and 1,999,494 of which have been designated as Series E Convertible Preferred
Stock (“Series E Preferred Stock”). As of March 31, 2022, there were 27,997,793 shares of common stock issued and
outstanding, , 0 shares of Series C Convertible Preferred Stock issued and outstanding, 0 shares of Series D Convertible Preferred Stock
issued and outstanding and 0 shares of Series E Convertible Preferred Stock issued and outstanding.

 

Our
Board, in consultation with counsel, determined that it was in the best interests of the Company and our stockholders to ratify, pursuant
to Section 204 of the Delaware General Corporation Law (“DGCL”) and Delaware common law, an increase in the number of authorized
shares of our common stock from 20,000,000 to 24,109,635 (the “Authorized Share Increase”) and the issuance of 4,109,635
shares of common stock (the “Authorized Share Increase Issuance”) upon conversion of the Series C Preferred Stock and the
exercise of certain December 2020 Warrants and Pre-Existing Warrants (the “Share Increase Ratification”). On March 3, 2021,
we filed a proxy statement in connection with a special meeting of stockholders (the “Special Meeting”) to be held at 10:00
a.m. Eastern time on March 31, 2021 to (i) ratify the Authorized Share Increase and the Authorized Share Increase Issuance, and (ii)
further increase the number of our authorized shares of common stock. On March 31, 2021, we did not have the requisite vote to approve
the Share Increase Ratification and the meeting was adjourned. At the reconvened Special Meeting on May 6, 2021, our stockholders voted
to approve the ratification of the Authorized Share Increase, but the stockholders did not approve the Share Increase Ratification.

 

On
August 17, 2021, at our 2021 Annual Meeting of Stockholders, our stockholders voted to approve an amendment to our Amended and Restated
Certificate of Incorporation to increase the number of shares of our common stock authorized for issuance from 24,109,635 shares to 40,000,000
shares.

 

Common
Stock

 

Voting
Rights

 

Each
stockholder has one vote for each share of common stock held on all matters submitted to a vote of stockholders. A stockholder may vote
in person or by proxy. Elections of directors are determined by a plurality of the votes cast and all other matters are decided by a
majority of the votes cast by those stockholders entitled to vote and present in person or by proxy.

 

Because
our stockholders do not have cumulative voting rights, stockholders holding a majority of the voting power of our shares of common stock
will be able to elect all of our directors. Our Amended & Restated Certificate of Incorporation and By-laws provide that stockholder
actions may be effected at a duly called meeting of stockholders or pursuant to written consent of the majority of stockholders.

 

Dividend
Rights

 

The
holders of outstanding shares of common stock are entitled to receive dividends out of funds legally available at the times and in the
amounts that the board of directors (the “Board”) may determine, provided that required dividends, if any, on preferred stock
have been paid or provided for. However, the current policy of our Board is to retain earnings, if any, for operations and growth.

 

No
Preemptive or Similar Rights

 

The
holders of our common stock have no preemptive, subscription, redemption or conversion rights. The rights, preferences and privileges
of holders of our common stock are subject to, and may be adversely affected by, the rights of the holders of any series of preferred
stock, which may be designated solely by action of the Board and issued in the future.

 

    	 

     

    

 

Right
to Receive Liquidation Distributions

 

Upon
liquidation, dissolution or winding-up, the holders of our common stock are entitled to share ratably in all assets that are legally
available for distribution.

 

The
NASDAQ Capital Market Listing

 

Our
common stock is listed on the NASDAQ Capital Market (“NASDAQ”) under the symbol “NAOV.”

 

Transfer
Agent and Registrar

 

The
transfer agent and registrar for our common stock is VStock Transfer, LLC, 18 Lafayette Place, Woodmere, NY 11598.

 

Options
and Warrants

 

As
of April 14, 2022, we had 2,659,999 shares of common stock issuable upon exercise of outstanding options and 2,309,347
shares of common stock issuable upon the exercise of warrants. There are no other outstanding warrants or options at this time.

 

Preferred
Stock

 

We
may issue any class of preferred stock in any series. The Board has the authority, subject to limitations prescribed under Delaware law
and the rights of the holders of any series of preferred stock, to issue preferred stock in one or more series, to establish from time
to time the number of shares to be included in each series and to fix the designation, powers, preferences and rights of the shares of
each series and any of its qualifications, limitations and restrictions. The number of authorized shares of preferred stock may be increased
or decreased (but not below the number of shares thereof then outstanding) by the affirmative vote of the holders of a majority of the
voting power of all of the then-outstanding shares of our capital stock entitled to vote thereon, without a vote of the holders of the
preferred stock, or of any series thereof, unless a vote of any such holders is required pursuant to the terms of any preferred stock
designation. The Board may authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the
voting power or other rights of the holders of the common stock. The issuance of preferred stock, while providing flexibility in connection
with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring or preventing
a change in control of our company and may adversely affect the market price of common stock and the voting and other rights of the holders
of common stock.

 

Series
C Convertible Preferred Stock

 

Conversion
Rights

 

Each
share of the Series C Preferred Stock is convertible into one (1) share of common stock, provided that the holder will be prohibited
from converting Series C Preferred Stock into shares of common stock if, as a result of such conversion, the holder would own more than
9.99% of the number of shares of common stock outstanding immediately after giving effect to the issuance of the shares of common stock
issuable upon conversion of the Series C Preferred Stock, or, at the election of a holder, together with its affiliates, would own more
than 9.99% of the number of shares of common stock outstanding immediately after giving effect to the issuance of the shares of common
stock issuable upon conversion of the Series C Preferred Stock. The conversion rate of the Series C Preferred Stock is subject to proportionate
adjustments for stock splits, reverse stock splits and similar events.

 

    	 

     

    

 

Dividend
Rights

 

Shares
of Series C Preferred Stock are not entitled to receive any dividends, unless and until specifically declared by the Board. However,
holders of Series C Preferred Stock are entitled to receive dividends on shares of Series C Preferred Stock equal (on an as-if-converted-to-common-stock
basis) to and in the same form as dividends actually paid on shares of the common stock when such dividends are specifically declared
by the Board. The Company is not obligated to redeem or repurchase any shares of Series C Preferred Stock. Shares of Series C Preferred
Stock are not otherwise entitled to any redemption rights, or mandatory sinking fund or analogous fund provisions.

 

Voting
Rights

 

Except
as provided in the Designation, Preferences, Rights and Limitations of Series C Preferred Stock or as otherwise required by law, each
holder of Series C Preferred Stock will be entitled to the number of votes equal to the number of shares of common stock into which such
share of Series C Preferred Stock could be converted, provided that the holder would be prohibited from converting Series C Preferred
Stock if, as a result of such conversion, the holder, together with its affiliates, would beneficially own more than 9.99% of the total
number of shares of our common stock then issued and outstanding, for purposes of determining the shares entitled to vote at any regular,
annual or special meeting of stockholders of the Company, and shall have voting rights and powers equal to the voting rights and powers
of the common stock (except as otherwise expressly provided herein or as required by law, voting together with the common stock as a
single class) and shall be entitled to notice of any stockholders’ meeting in accordance with the By-laws of the Company. Fractional
votes shall not, however, be permitted and any fractional voting rights shall be rounded to the nearest whole number (with one-half being
rounded upward). We may not, without the written consent of holders of a majority of the then issued and outstanding shares of Series
C Preferred Stock, increase the number of authorized shares of Series C Preferred Stock.

 

Liquidation
Rights

 

Upon
any liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary, the holders of Series C Preferred Stock
are entitled to receive, pari passu with the holders of common stock, out of the assets available for distribution to stockholders an
amount equal to such amount per share as would have been payable had all shares of Series C Preferred Stock been converted into common
stock immediately before such liquidation, dissolution or winding up, without giving effect to any limitation on conversion as a result
of the Beneficial Ownership Limitation, as described above.

 

Series
D Convertible Preferred Stock

 

Conversion
Rights

 

Each
share of the Series D Preferred Stock is convertible into one thousand (1,000) shares of common stock, provided that the holder will
be prohibited from converting Series D Preferred Stock into shares of common stock if, as a result of such conversion, the holder would
own more than 9.99% of the number of shares of common stock outstanding immediately after giving effect to the issuance of the shares
of common stock issuable upon conversion of the Series D Preferred Stock, or, at the election of a holder, together with its affiliates,
would own more than 9.99% of the number of shares of common stock outstanding immediately after giving effect to the issuance of the
shares of common stock issuable upon conversion of the Series D Preferred Stock. The conversion rate of the Series D Preferred Stock
is subject to proportionate adjustments for stock splits, reverse stock splits and similar events.

 

Dividend
Rights

 

Shares
of Series C Preferred Stock are not entitled to receive any dividends, unless and until specifically declared by the Board. Series D
Preferred Stockholders (“Series D Holders”) are entitled to receive, and the Company shall pay, dividends on shares of Series
D Preferred Stock equal (on an as-if-converted-to-common-stock basis) to and in the same form as dividends actually paid on shares of
the common stock when, as and if such dividends are paid on shares of the common stock. No other dividends shall be paid on shares of
Series D Preferred Stock.

 

    	 

     

    

 

Voting
Rights

 

Except
as provided in the Series D Preferred Stock Certificate of Designation or as otherwise required by law, Series D Holders shall have no
voting rights. However, as long as any shares of Series D Preferred Stock are outstanding, the Company shall not, without the affirmative
vote of the Series D Holders of a majority of the then outstanding shares of the Series D Preferred Stock, (a) alter or change adversely
the powers, preferences or rights given to the Series D Preferred Stock or alter or amend the Series D Preferred Stock Certificate of
Designation, (b) amend its certificate of incorporation or other charter documents in any manner that adversely affects any rights of
the Series D Holders, (c) increase the number of authorized shares of Series D Preferred Stock, or (d) enter into any agreement with
respect to any of the foregoing.

 

Liquidation
Rights

 

Upon
any liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary, the Series D Holders shall be entitled to
receive out of the assets, whether capital or surplus, of the Company the same amount that a holder of common stock would receive if
the Series D Preferred Stock were fully converted (disregarding for such purpose any conversion limitations hereunder) to common stock
which amounts shall be paid pari passu with all holders of common stock. The Company shall mail written notice of any such liquidation,
not less than 30 days prior to the payment date stated therein, to each Series D Holder.

 

Series
E Convertible Preferred Stock

 

Conversion
Rights

 

Each
share of Series E Preferred Stock is convertible at any time and from time to time at the option of a holder of Series E Preferred Stock
(a “Series E Holder”) into one share of our common stock, provided that each holder is prohibited from converting Series
E Preferred Stock into shares of our common stock if, as a result of such conversion, any such holder, together with its affiliates,
would own more than 9.99% of the total number of shares of our common stock then issued and outstanding. This limitation may be waived
with respect to a holder upon such holder’s provision of not less than 61 days’ prior written notice to the Company. The
conversion rate of the Series E Preferred Stock is subject to proportionate adjustments for stock splits, reverse stock splits and similar
events.

 

Dividend
Rights

 

Shares
of Series E Preferred Stock are not entitled to receive any dividends, unless and until specifically declared by the Board. However,
Series E Holders are entitled to receive dividends on shares of Series E Preferred Stock equal (on an as-if-converted-to-common-stock
basis) to and in the same form as dividends actually paid on shares of the common stock when such dividends are specifically declared
by the Board. The Company is not obligated to redeem or repurchase any shares of Series E Preferred Stock. Shares of Series E Preferred
Stock are not otherwise entitled to any redemption rights, or mandatory sinking fund or analogous fund provisions.

 

Voting
Rights

 

Each
Series E Holder shall be entitled to the number of votes equal to the number of shares of our common stock equal to the voting ratio,
which, for each share of Series E Preferred Stock, is equal to $2.00 divided by $3.53. Fractional votes shall not, however, be permitted
and any fractional voting rights resulting from the above formula (after aggregating all shares into which shares of Series E Preferred
Stock held by each Series E Holder could be converted) shall be rounded to the nearest whole number (with one-half being rounded upward).

 

Liquidation
Rights

 

Upon
liquidation, dissolution or winding up of the Company, whether voluntary or involuntary, each Series E Holder shall be entitled to receive
the amount of cash, securities or other property to which such holder would be entitled to receive with respect to such shares of Series
E Preferred Stock if such shares had been converted to our common stock immediately prior to such liquidation.

 

    	 

     

    

 

Delaware
Anti-Takeover Law and Provisions of our Certificate of Incorporation and Bylaws

 

Delaware
Anti-Takeover Law

 

We
are subject to Section 203 of the Delaware General Corporation Law (the “DGCL”). Section 203 generally prohibits a public
Delaware corporation from engaging in a “business combination” with an “interested stockholder” for a period
of three years after the date of the transaction in which the person became an interested stockholder, unless:

 

	 	●	prior
    to the date of the transaction, the board of directors of the corporation approved either the business combination or the transaction
    which resulted in the stockholder becoming an interested stockholder;
	 	 	 
	 	●	the
    interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced,
    excluding for purposes of determining the number of shares outstanding (i) shares owned by persons who are directors and also officers
    and (ii) shares owned by employee stock plans in which employee participants do not have the right to determine confidentially whether
    shares held subject to the plan will be tendered in a tender or exchange offer; or
	 	 	 
	 	●	on
    or subsequent to the date of the transaction, the business combination is approved by the board and authorized at an annual or special
    meeting of stockholders, and not by written consent, by the affirmative vote of at least 66 2/3% of the outstanding voting stock
    which is not owned by the interested stockholder.
	 	 	 
	 	Section
    203 defines a business combination to include:
	 	 	 
	 	●	any
    merger or consolidation involving the corporation and the interested stockholder;
	 	 	 
	 	●	any
    sale, transfer, pledge or other disposition involving the interested stockholder of 10% or more of the assets of the corporation;
	 	 	 
	 	●	subject
    to exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the
    interested stockholder; or
	 	 	 
	 	●	the
    receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits provided
    by or through the corporation.

 

In
general, Section 203 defines an interested stockholder as any entity or person beneficially owning 15% or more of the outstanding voting
stock of the corporation and any entity or person affiliated with, or controlling, or controlled by, the entity or person. The term “owner”
is broadly defined to include any person that, individually, with or through that person’s affiliates or associates, among other
things, beneficially owns the stock, or has the right to acquire the stock, whether or not the right is immediately exercisable, under
any agreement or understanding or upon the exercise of warrants or options or otherwise or has the right to vote the stock under any
agreement or understanding, or has an agreement or understanding with the beneficial owner of the stock for the purpose of acquiring,
holding, voting or disposing of the stock.

 

The
restrictions in Section 203 do not apply to corporations that have elected, in the manner provided in Section 203, not to be subject
to Section 203 of the DGCL or, with certain exceptions, which do not have a class of voting stock that is listed on a national securities
exchange or authorized for quotation on the Nasdaq Stock Market or held of record by more than 2,000 stockholders. Our certificate of
incorporation and bylaws do not opt out of Section 203.

 

Section
203 could delay or prohibit mergers or other takeover or change in control attempts with respect to us and, accordingly, may discourage
attempts to acquire us even though such a transaction may offer our stockholders the opportunity to sell their stock at a price above
the prevailing market price.

 

    	 

     

    

 

Amended
and Restated Certificate of Incorporation and By-laws

 

The
provisions of our Amended and Restated Certificate of Incorporation and By-laws may delay or discourage transactions involving an actual
or potential change in our control or change in our management, including transactions in which stockholders might otherwise receive
a premium for their shares, or transactions that our stockholders might otherwise deem to be in their best interests. Therefore, these
provisions could adversely affect the price of our common stock. Among other things, our Certificate of Incorporation and By-laws:

 

	 	●	permit
    our board of directors to issue up to 11,000,000 shares of preferred stock, without further action by the stockholders, with any
    rights, preferences and privileges as they may designate, including the right to approve an acquisition or other change in control;
	 	 	 
	 	●	provide
    that the authorized number of directors may be changed only by resolution of a majority of the total number of authorized directors
    whether or not there exist any vacancies in previously authorized directorships (the “Whole Board”);
	 	 	 
	 	●	provide
    that all vacancies, including newly created directorships, may, except as otherwise required by law, be filled by the affirmative
    vote of a majority of directors then in office, even if less than a quorum;
	 	 	 
	 	●	do
    not provide for cumulative voting rights (therefore allowing the holders of a majority of the shares of common stock entitled to
    vote in any election of directors to elect all of the directors standing for election, if they should so choose);
	 	 	 
	 	●	provide
    that special meetings of our stockholders may be called only by a resolution adopted by a majority of the Whole Board; and
	 	 	 
	 	●	set
    forth an advance notice procedure with regard to the nomination, other than by or at the direction of our Board, of candidates for
    election as directors and with regard to business to be brought before a meeting of stockholders.Exhibit 4.1

 

DESCRIPTION OF SECURITIES
REGISTERED PURSUANT TO

SECTION 12 OF THE SECURITIES
EXCHANGE ACT OF 1934, AS AMENDED

 

General

 

The following description summarizes the most
important terms of our securities registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended. This summary does
not purport to be complete and is qualified in its entirety by the provisions of our amended and restated Articles of Incorporation (“Articles
of Incorporation”). For a complete description of our securities, you should refer to our Articles of Incorporation and the applicable
provisions of Chapters 78 and 92A of the Nevada Revised Statutes (the “Nevada Statutes”).

 

We are incorporated as a Nevada company, and our
affairs are governed by our Articles of Incorporation and the laws of the State of Nevada. As
used in this section, “we,” “us,” “our,” and “the Company” mean Heyu Biological Technology
Corporation and its successors, but not any of its subsidiaries.

 

Authorized Capital Stock

 

Under our Articles of Incorporation, our authorized
capital stock consists of 2,000,000,000 shares of common stock, par value $0.001 per share. As of March 31, 2022, we had 1,032,466,000
shares of common stock outstanding, held of record by 668 stockholders. This number excludes any estimate by us of the number of beneficial
owners of shares held in street name, the accuracy of which cannot be guaranteed.

 

Common Stock.

 

Our common stock is listed on The OTC Pink
Market, under the symbol “HYBT.”

 

Voting. Holders of common stock are
entitled to one vote per share. Holders of our common stock are not entitled to cumulative voting in the election of directors.

 

Dividends. Except as provided by law
or in our articles of incorporation, the holders of common stock will be entitled to such cash dividends as may be declared from time
to time by the board of directors of the Company (the “Board of Directors”) from funds available.

 

Liquidation. Upon liquidation, dissolution
or winding up of the Company, the holders of common stock will be entitled to receive pro rata all assets available for distribution
to such holders after payment of our liabilities.

 

Other Terms. Holders of common stock
are not entitled to preemptive rights, nor is the common stock subject to redemption.

 

Provisions of our Articles of Incorporation
and Bylaws with Anti-Takeover Implications

 

Certain provisions of our Articles of Incorporation
and amended and restated bylaws (“Bylaws”) deal with matters of corporate governance and the rights of stockholders. Under
our Articles of Incorporation, our Board of Directors may set the voting rights, preferences and other terms thereof. Our Bylaws provide
that a special meeting of stockholders may be called only by the President, or by the President or Secretary at the request of a majority
of the directors or stockholders owning not less than 25% of our issued and outstanding voting stock. Such provisions, together with certain
provisions of the Nevada Statutes (see “Nevada Anti-Takeover Statutes”), could be deemed to have an anti-takeover effect and
discourage takeover attempts not first approved by our Board of Directors. This may include takeovers that certain stockholders may deem
to be in their best interest. Any such discouraging effect on takeover attempts could potentially depress the market price of our common
stock or inhibit temporary fluctuations in the market price of our common stock that could result from actual or rumored takeover
attempts.

 

     

     

    

 

Nevada Anti-Takeover Statutes

 

Business Combinations Act

 

We are subject to Nevada’s anti-takeover
law because we have not opted out of the provisions of Sections 78.411-78.444 of the Nevada Statutes under the terms of our Articles of
Incorporation. This law provides that specified persons who, together with affiliates and associates, own, or within two years did own,
10% or more of the outstanding voting stock of a corporation cannot engage in specified business combinations with the corporation for
a period of two years after the date on which the person became an interested stockholder. The law defines the term “business combination”
to encompass a wide variety of transactions with or caused by an interested stockholder, including mergers, asset sales and other transactions
in which the interested stockholder receives or could receive a benefit on other than a pro rata basis with other stockholders. This provision
may have an anti-takeover effect for transactions not approved in advance by our Board of Directors, including discouraging takeover attempts
that might result in a premium over the market price for the shares of our common stock.

 

Control Share Statute

 

A corporation is subject to Nevada’s control
share law if it has more than 200 stockholders, at least 100 of whom are stockholders of record and residents of Nevada, and if the corporation
does business in Nevada, including through an affiliated corporation. This control share law may have the effect of discouraging corporate
takeovers. We currently have less than 100 stockholders of record who are residents of Nevada.

 

The control share law focuses on the acquisition
of a "controlling interest," which means the ownership of outstanding voting shares that would be sufficient, but for the operation
of the control share law, to enable the acquiring person to exercise the following proportions of the voting power of the corporation
in the election of directors: (1) one-fifth or more but less than one-third; (2) one-third or more but less than a majority; or (3) a
majority or more. The ability to exercise this voting power may be direct or indirect, as well as individual or in association with others.

 

The effect of the control share law is that an
acquiring person, and those acting in association with that person, will obtain only such voting rights in the control shares as are conferred
by a resolution of the stockholders of the corporation, approved at a special or annual meeting of stockholders. The control share law
contemplates that voting rights will be considered only once by the other stockholders. Thus, there is no authority to take away voting
rights from the control shares of an acquiring person once those rights have been approved. If the stockholders do not grant voting rights
to the control shares acquired by an acquiring person, those shares do not become permanent non-voting shares. The acquiring person is
free to sell the shares to others. If the buyer or buyers of those shares themselves do not acquire a controlling interest, the shares
are not governed by the control share law.

 

If control shares are accorded full voting rights
and the acquiring person has acquired control shares with a majority or more of the voting power, a stockholder of record, other than
the acquiring person, who did not vote in favor of approval of voting rights, is entitled to demand fair value for such stockholder's
shares.

 

Transfer Agent

 

The transfer agent for our capital stock is Standard
Registrar and Transfer Company, Inc., located at 440 East 400 South, Suite 200, Salt Lake City, UT 84111. Their telephone number is (801)
571-8844.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00343-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00343-of-00352.parquet"}]]